{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:49:48Z","timestamp":1786985388938,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bja.2023.12.032","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T14:45:45Z","timestamp":1706798745000},"page":"541-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of the orexin receptor 2 agonist danavorexton on emergence from general anaesthesia and opioid-induced sedation, respiratory depression, and analgesia in rats and monkeys"],"prefix":"10.1016","volume":"132","author":[{"given":"Motohisa","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cronican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-3647","authenticated-orcid":false,"given":"Haruhide","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2023.12.032_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/LRA.S230728","article-title":"Delayed emergence from anesthesia: what we know and how we act","volume":"13","author":"Cascella","year":"2020","journal-title":"Local Reg Anesth"},{"key":"10.1016\/j.bja.2023.12.032_bib2","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/aas.12717","article-title":"Post-anaesthetic emergence delirium in adults: incidence, predictors and consequences","volume":"60","author":"Munk","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bja.2023.12.032_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.21037\/apm.2019.10.09","article-title":"Opioid utility function: methods and implications","volume":"9","author":"van Dam","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.bja.2023.12.032_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","article-title":"Incidence, reversal, and prevention of opioid-induced respiratory depression","volume":"112","author":"Dahan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.12688\/f1000research.21738.1","article-title":"Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants","volume":"9","author":"Imam","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.bja.2023.12.032_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nrn2372","article-title":"General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal","volume":"9","author":"Franks","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bja.2023.12.032_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bja.2023.12.032_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2023.12.032_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1152\/japplphysiol.00914.2004","article-title":"Orexin stimulates breathing via medullary and spinal pathways","volume":"98","author":"Young","year":"2005","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.bja.2023.12.032_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.bja.2023.12.032_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resp.2014.06.006","article-title":"Orexin induces excitation of respiratory neuronal network in isolated brainstem spinal cord of neonatal rat","volume":"200","author":"Sugita","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bja.2023.12.032_bib12","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1111\/bph.12784","article-title":"Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats","volume":"171","author":"Zhang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bja.2023.12.032_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.resp.2008.03.011","article-title":"Orexinergic modulation of breathing across\u00a0vigilance states","volume":"164","author":"Kuwaki","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bja.2023.12.032_bib14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fphys.2019.01200","article-title":"Orexin neurons contribute to central modulation of respiratory drive by progestins on ex\u00a0vivo newborn rodent preparations","volume":"10","author":"Loiseau","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.bja.2023.12.032_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.03.053","article-title":"A\u00a0review of the role of orexin system in pain modulation","volume":"90","author":"Razavi","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bja.2023.12.032_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172794","article-title":"TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice","volume":"187","author":"Yukitake","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bja.2023.12.032_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/acsmedchemlett.1c00626","article-title":"Discovery of TAK-925 as a potent, selective, and brain-penetrant orexin 2 receptor agonist","volume":"13","author":"Fujimoto","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bja.2023.12.032_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13878","article-title":"Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals","author":"Evans","year":"2023","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.bja.2023.12.032_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00000542-197401000-00012","article-title":"Determination of anesthetic requirement in rats","volume":"40","author":"White","year":"1974","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neulet.2017.10.034","article-title":"Evaluation of prolonged administration of isoflurane on cerebral blood flow and default mode network in macaque monkeys anesthetized with different maintenance doses","volume":"662","author":"Li","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bja.2023.12.032_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/ALN.0000000000000490","article-title":"5-HT1A receptor agonist Befiradol reduces fentanyl-induced respiratory depression, analgesia, and sedation in rats","volume":"122","author":"Ren","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125509","article-title":"Sleep\/wake dynamics changes during maturation in rats","volume":"10","author":"Gradwohl","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bja.2023.12.032_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2131\/jts.35.863","article-title":"Measurement of respiratory function using whole-body plethysmography in unanesthetized and unrestrained nonhuman primates","volume":"35","author":"Iizuka","year":"2010","journal-title":"J\u00a0Toxicol Sci"},{"key":"10.1016\/j.bja.2023.12.032_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2019.104562","article-title":"The pronociceptive role of 5-HT6 receptors in ventrolateral orbital cortex in a rat formalin test model","volume":"131","author":"Zhang","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bja.2023.12.032_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0304-3959(95)01441-1","article-title":"Characterization of a rat model of incisional pain","volume":"64","author":"Brennan","year":"1996","journal-title":"Pain"},{"key":"10.1016\/j.bja.2023.12.032_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ALN.0b013e318278c896","article-title":"Activation of D1 dopamine receptors induces emergence from isoflurane general anesthesia","volume":"118","author":"Taylor","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/ALN.0b013e3182518bfc","article-title":"Active emergence from propofol general anesthesia is induced by methylphenidate","volume":"116","author":"Chemali","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50613-2","article-title":"Electrocortical changes associating sedation and respiratory depression by the opioid analgesic fentanyl","volume":"9","author":"Montandon","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bja.2023.12.032_bib29","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2207531119","article-title":"Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients","volume":"119","author":"Evans","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2023.12.032_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuropharm.2009.08.020","article-title":"The neuropharmacology of ADHD drugs in\u00a0vivo: insights on efficacy and safety","volume":"57","author":"Heal","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bja.2023.12.032_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704851","article-title":"Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test","volume":"137","author":"Yamamoto","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bja.2023.12.032_bib32","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","article-title":"Averting opioid-induced respiratory depression without affecting analgesia","volume":"128","author":"Dahan","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2023.12.032_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ALN.0000000000002161","article-title":"Nonpeptide orexin-2 receptor agonist attenuates morphine-induced sedative effects in rats","volume":"128","author":"Toyama","year":"2018","journal-title":"Anesthesiology"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:31:39Z","timestamp":1720585899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091224000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0007091224000011"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2023.12.032","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the orexin receptor 2 agonist danavorexton on emergence from general anaesthesia and opioid-induced sedation, respiratory depression, and analgesia in rats and monkeys","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2023.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Takeda Pharmaceutical Company Limited. Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}]}}